Wells Fargo & Company Edwards Lifesciences Corp Put Options Transaction History
Wells Fargo & Company
- $407 Billion
- Q2 2024
Put Options
1 transactions
Others Institutions Holding EW
# of Institutions
1,340Shares Held
467MCall Options Held
2.56MPut Options Held
2.56M-
Vanguard Group Inc Valley Forge, PA53.6MShares$3.53 Billion0.1% of portfolio
-
Black Rock Inc. New York, NY51MShares$3.36 Billion0.11% of portfolio
-
State Street Corp Boston, MA26MShares$1.71 Billion0.11% of portfolio
-
Alliancebernstein L.P. New York, NY20.3MShares$1.34 Billion0.68% of portfolio
-
Wellington Management Group LLP Boston, MA16.9MShares$1.11 Billion0.29% of portfolio
About Edwards Lifesciences Corp
- Ticker EW
- Exchange NYSE
- Sector Healthcare
- Industry Medical Devices
- Shares Outstandng 618,259,968
- Market Cap $40.7B
- Description
- Edwards Lifesciences Corporation provides products and technologies for structural heart disease, and critical care and surgical monitoring in the United States, Europe, Japan, and internationally. It offers transcatheter heart valve replacement products for the minimally invasive replacement of heart valves; and transcatheter heart valve repair...